A Study of the Safety and Efficacy of Glimepiride, Gliclazide, Repaglinide or Acarbose When Added to Sitagliptin + Metformin Combination Therapy in Chinese Participants With Diabetes (MK-0431-313)
Clinical trial NCT01709305 · COMPLETED
Trial details
- NCT number
- NCT01709305
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2012-11-08
- Primary completion
- 2015-04-17
- Enrollment
- 5570
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.